ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AFFX Affymetrix, Inc.

14.01
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Affymetrix, Inc. NASDAQ:AFFX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 14.01 0 01:00:00

Affymetrix Delays Thermo Fisher Merger Vote After Higher Origin Bid

23/03/2016 4:59pm

Dow Jones News


Affymetrix (NASDAQ:AFFX)
Historical Stock Chart


From Oct 2019 to Oct 2024

Click Here for more Affymetrix Charts.
By Anne Steele 

Affymetrix Inc. on Wednesday postponed a vote on its proposed tie-up with Thermo Fisher Scientific Inc., saying a new unsolicited bid from Origin Technologies Corp. could reasonably lead to a superior proposal.

The company said that its board continues to recommend its stockholders vote in favor of the merger agreement with Thermo Fisher, and said it hasn't determined that the Origin proposal is in fact a superior proposal. Affymetrix said the board recommends against the Origin proposal.

The stockholder meeting scheduled for Thursday is now pushed back a week to March 31.

On Tuesday, Origin--a newly formed entity owned by former Affymetrix executives--raised its unsolicited offer for the genetic-analysis company by 5.6% in another attempt to disrupt the planned merger with Thermo Fisher.

Origin increased its all-cash offer to $17 a share, valuing Affymetrix at about $1.58 billion and trumping its previous offer of $16.10 a share. In January, Thermo Fisher agreed to buy Affymetrix for about $14 a share, or roughly $1.3 billion, in a bid to boost its biogenetic-analysis portfolio. The Thermo deal offered a 52% premium to Affymetrix's stock price before the announcement.

Affymetrix shares added 4.5% to $15.01 midday, suggesting some shareholders are expecting any deal for Affymetrix will be higher than Thermo's bid of $14.

On Wednesday, Thermo Fisher fired back at Origin, calling its own proposal the only "bona fide" bid for Affymetrix shareholders.

Thermo Fisher Chief Executive Marc Casper said their transaction, which has been unanimously approved by both boards, provides Affymetrix shareholders with a "significant premium, is fully-financed and received all required regulatory approvals."

Evercore analyst Ross Muken said Origin's new bid complicates matters, and Affymetrix's board is likely required to take it seriously to comply with their fiduciary duty.

Write to Anne Steele at Anne.Steele@wsj.com

 

(END) Dow Jones Newswires

March 23, 2016 12:44 ET (16:44 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.

1 Year Affymetrix Chart

1 Year Affymetrix Chart

1 Month Affymetrix Chart

1 Month Affymetrix Chart

Your Recent History

Delayed Upgrade Clock